CEO of Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics is a biotechnology company focused on discovering and developing precision medicines that target disease-causing proteins.
IMV is a Canadian biopharmaceutical company focused on developing immunotherapies for serious human diseases using its proprietary lipid-based delivery system, which the company calls DPX.